Kota Kinabalu, Malaysia
Kota Kinabalu, Malaysia

Time filter

Source Type

SANTA FE, N.M., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Sigma Labs, Inc. (OTCQB:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced the pricing of a firm commitment underwritten public offering (the “Offering”) of 1,410,000 units (“Units”) at an offering price of $4.13 per Unit, with each Unit consisting of one share of the Company’s common stock and one warrant, with each warrant giving the investor the right to acquire one share of common stock at an exercise price of $4.00 per share. The shares of common stock and associated warrants are immediately separable and will be issued separately. Gross proceeds to the Company from the Offering will be approximately $5.8 million before deducting underwriting discounts and commissions and other estimated Offering expenses payable by the Company. The Company has granted the underwriter a 45-day option to purchase (i) up to 211,500 additional shares of common stock at the public offering price per Unit less the price per warrant included in the Unit and/or (ii) additional warrants to purchase up to 211,500 additional shares of common stock at a purchase price of $0.01 per warrant to cover over-allotments, if any. The Offering is expected to close on February 21, 2017, subject to customary closing conditions. The common stock and the warrants will begin trading on the NASDAQ Capital Market under the symbols "SGLB" and "SGLBW," respectively, effective as of market open today.  All Unit, share and per share and Unit amounts described above reflect a 1-for-2 reverse stock split that became effective as of today. Dawson James Securities, Inc. acted as the sole underwriter for the offering. Copies of the complete final prospectus related to the offering may be obtained from Dawson James Securities, Inc., Attention: Prospectus Department, 1 North Federal Highway, 5th Floor, Boca Raton, FL 33432, or from mmaclaren@dawsonjames.com, or by calling toll free at 866.928.0928. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Sigma Labs, Inc. Sigma Labs, Inc. is a provider of quality assurance software under the PrintRite3D® brand and a developer of advanced, in-process, non-destructive quality assurance software for commercial firms worldwide seeking productive solutions for advanced manufacturing. For more information please visit www.sigmalabsinc.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." These forward-looking statements are subject to a number of risks, uncertainties and assumptions that could adversely affect us, including the risks set forth in Sigma's most recent annual report on Form 10-K. The forward-looking statements in this press release are made only as of the date of this press release. Sigma undertakes no obligation to update any of these forward-looking statements, whether as a result of new information, future events or otherwise.


News Article | October 28, 2016
Site: www.marketwired.com

Fully Integrated Media Company, including Comic Books, Television Shows, Board Games, and Distribution of Tourist Information, to Present on November 1 SAN DIEGO, CA--(Marketwired - Oct 26, 2016) - IDW Media Holdings, Inc. ( : IDWM), parent company to IDW Publishing, an award-winning comic book and graphic novel publisher, IDW Entertainment, with prominent television shows such as Wynonna Earp and Dirk Gently's Holistic Detective Agency, IDW Games, producer of tabletop board and card games, IDW Limited, creator of high-end print collectibles, and CTM, distributor of tourism information, today announced that Chief Executive Officer Ted Adams and Chief Financial Officer Les Rozner will present at the Sidoti & Company Fall 2016 Emerging Growth Convention in New York City on Tuesday, November 1. Mr. Adams and Mr. Rozner will give a formal presentation at 2:25 PM ET and will be available for one-on-one meetings throughout the day. Interested investors can schedule a meeting by contacting IDW Media or by clicking here: https://www.meetmax.com/sched/event_38449/investor_reg_new.html?attendee_role_id=INVESTOR Where: New York Marriott Marquis - 5th Floor 1535 Broadway, New York, NY 10036 For general information about the event, please visit the conference website: http://www.meetmax.com/sched/event_38449/~public/conference_home.html About the Sidoti & Company Emerging Growth Convention: The Sidoti & Company Fall 2016 Emerging Growth Convention will focus on companies with market capitalizations of $600 million and less, connecting their executive management teams with institutional and high-net-worth investors while building interest and visibility into the most overlooked, undervalued segment of the equity market. About Sidoti & Company, LLC: Sidoti & Company, founded in 1999, is Wall Street's preeminent provider of equity research generally focused on companies with market capitalizations of under $3 billion. Sidoti & Company's approach affords institutional investor clients a combination of high-quality research of over 250 companies, a small- and micro-cap company focused nationwide sales effort, broad access to corporate management teams, and extensive trading support. Sidoti & Company serves nearly 500 institutional clients in the U.S., Canada, and the U.K., including many leading managers of portfolios with $200 million to $2 billion of assets. They also host a biannual Emerging Growth Convention in New York, and are a provider of company sponsored research. For more information, please refer to Sidoti & Company About IDW Media Holdings (www.idwmediaholdings.com) IDW Media Holdings, Inc. ( : IDWM) is a fully integrated media company, which includes publishing, games, entertainment, and the San Diego Comic Art Gallery. IDW Publishing's comic book and graphic novel catalog includes some of the world's most popular entertainment brands including Transformers, My Little Pony, Star Trek, Teenage Mutant Ninja Turtles, Ghostbusters, and Disney's classic characters. At IDW's core is its commitment to creator-owned comics including 30 Days of Night, Locke & Key, Wormwood, Ragnarök, V-Wars, and Archangel. The acclaimed and award-winning imprints; Top Shelf, The Library of American Comics, Yoe! Books, March and Artist Editions, showcasing the greatest original art ever published in American comic books. IDW Games' diverse line-up includes the international phenomenon Machi Koro, as well as hit licensed games such as X-Files, Back to the Future, The Godfather, and TMNT. IDW Entertainment currently serves as the worldwide distributor of Wynonna Earp airing on the Syfy Channel in the U.S. and is producing BBC America's Dirk Gently, based the best seller by Douglas Adams starring Elijah Wood and Sam Barnett, and Brooklyn Animal Control for USA Network. CTM Media Group Inc. a subsidiary of IDW Media Holdings is one of North America's largest distributors of tourism information distributing over 100 million brochures last year. Forward Looking Statements: All statements above that are not purely about historical facts, including, but not limited to, those in which we use the words "believe," "anticipate," "expect," "plan," "intend," "estimate," "target" and similar expressions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. While these forward-looking statements represent our current judgment of what may happen in the future, actual results may differ materially from the results expressed or implied by these statements due to numerous important factors. Our filings with the SEC provide detailed information on such statements and risks, and should be consulted along with this release. To the extent permitted under applicable law, we assume no obligation to update any forward-looking statements.


FRANKFURT, Germany--(BUSINESS WIRE)--Harris Williams & Co. Ltd, a preeminent middle market investment bank focused on the advisory needs of clients worldwide, exclusively advised Stirling Square Capital Partners (SSCP), a leading European mid-market private equity firm, on the pending sale of its portfolio company ESE World B.V. (ESE) to RPC Group Plc (RPC Group; LON:RPC). ESE is a leading European provider of temporary waste storage solutions. With the acquisition, RPC Group continues its successful acquisition activities in Europe. The pending transaction is expected to close in the first quarter of 2017 and is being led by Jeffery Perkins, Lars Friemann, Florian Ripperger and Konstantin Molinari of Harris Williams & Co.’s Frankfurt office as well as Patrick McNulty and Brad Morrison of the firm’s Industrials Group. Jakob Förschner, a Partner at SSCP, added, “ESE represents a true success story in the waste storage solutions market, having been transformed into Europe’s largest ‘pure-play’ waste storage solutions provider and innovation leader in its market. We are proud to have accompanied ESE on this path and are absolutely convinced that RPC Group is the right partner to support ESE’s growth in the future. Harris Williams & Co. has been an excellent partner throughout the entire transaction, supporting us to achieve an outcome that exceeded our expectations. The senior-level attention, high quality work, thoughtful advice and in-depth industry know-how were critical in making this a successful transaction.” Jeffery Perkins, a managing director at Harris Williams & Co., stated, “ESE is an innovation leader in its market and the only company that has successfully developed production techniques to produce containers using up to 100% recycled material. We were delighted to be able to advise SSCP and the management team on finding the right partner to continue ESE’s success story. We are convinced that together with RPC Group, Björn Hedenström and his team at ESE are well positioned to continue their growth.” With over 80 million containers delivered, ESE is Europe’s largest “pure play” temporary waste storage solutions provider with well-known regional and pan-European brands. The company services a broad customer base ranging from local municipalities to private waste service providers. ESE’s manufacturing footprint comprises two facilities in Germany and France, and one R&D center in Germany, employing approximately 600 full time employees. For the year ending 31 December 2016, the company is expecting to achieve revenues in excess of €200 million whilst consuming circa 45kt of polymers. Björn Hedenström, Chief Executive Officer of ESE, will continue to lead the business as an independent business unit within RPC Group going forward. SSCP is a private equity firm which invests across Europe in mid-market companies with enterprise values between €50 million and €500 million. SSCP manages three funds and a number of co-investment positions, with total committed capital in excess of €1 billion. The firm has invested in 19 portfolio companies since establishment in 2002, and with seven significant bolt-ons, this has involved 26 major acquisitions. RPC Group is a leading international design and engineering company of plastic products for both packaging and non-packaging markets. The acquisition of ESE represents a strategic opportunity to enter into a high added value, polymer consuming segment in a stable and growing European market, with good management and well-established market positions supported by industry recognized branded products. RPC employs more than 20,000 people in over 31 countries worldwide. Harris Williams & Co. (www.harriswilliams.com), a member of The PNC Financial Services Group, Inc. (NYSE:PNC), is a preeminent middle market investment bank focused on the advisory needs of clients worldwide. The firm has deep industry knowledge, global transaction expertise and an unwavering commitment to excellence. Harris Williams & Co. provides sell-side and acquisition advisory, restructuring advisory, board advisory, private placements and capital markets advisory services. Harris Williams & Co.’s Industrials Group has experience across a variety of sectors, including advanced manufacturing; aggregates, metals, and mining; building products; chemicals and specialty materials; industrial technology; and packaging. For more information on the firm’s Industrials Group and other recent transactions, visit the Industrials Group’s section of the Harris Williams & Co. website. Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which is private limited company incorporated under English law with its registered office at 5th Floor, 6 St. Andrew Street, London EC4A 3AE, UK, registered with the Registrar of Companies for England and Wales (registration number 7078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. is a trade name under which Harris Williams LLC and Harris Williams & Co. Ltd conduct business.


LONDON--(BUSINESS WIRE)--Harris Williams & Co. Ltd, a preeminent middle market investment bank focused on the advisory needs of clients worldwide, announces the sale of The Leisure Pass Group Holdings Ltd. (Leisure Pass) to Exponent Private Equity (Exponent). Leisure Pass is a leading city attraction pass provider with operations in 19 major international cities across Europe and North America. Harris Williams & Co. served as the exclusive financial advisor to Leisure Pass, a portfolio company of Primary Capital (Primary). The transaction was led by Thierry Monjauze, Will Bain and Sylvain Noblet of Harris Williams & Co.’s London office, with the support of Michael Wilkins of the firm’s San Francisco office. “Since its inception, Leisure Pass has revolutionized the sightseeing experience for millions of tourists worldwide, delivering exceptional value for both tourists and attractions,” said Thierry Monjauze, a managing director in Harris Williams & Co.’s Technology, Media & Telecom (TMT) Group. “We look forward to watching the continued growth and development of the company as it enters this new and exciting phase.” Will Bain, a director in the firm’s Consumer Group added, “The team at Leisure Pass has built a fantastic business and has had considerable success scaling the company’s model internationally. Under Primary’s ownership the company has more than doubled revenue and nearly tripled its EBITDA. We have thoroughly enjoyed working with both Primary and Leisure Pass on this transaction and we wish the team all the very best for the future under Exponent’s ownership.” Leisure Pass is a leading global interface between tourists and attractions, facilitating the sightseeing experience for millions of customers each year. The company packages together a large number of city attractions into a pass which entitles the pass holder access to attractions over a defined period of time. This pass provides customers with cost savings against published gate prices, convenience, fast-track entry plus additional benefits including guidebooks and concierge services. Founded in 1999 and based in London, Leisure Pass processes more than £1.5 million passes per annum. Primary is a leading provider of private equity finance for UK based growth companies valued between £20 million and £100 million. It invests in a broad range of sectors with particular experience in consumer, leisure, business and support services, TMT and industrial products/services. It is currently investing from its fourth fund, with commitments totaling £227.5 million. Exponent is a private equity firm investing in UK and Ireland headquartered businesses with enterprise values between £75 million and £350 million. Its team, which has over 170 years of collective experience, invests in businesses across a broad range of sectors, including consumer, industrials, education and services. Exponent is currently investing from its third fund, with commitments totaling £1 billion, raised in 2015. Harris Williams & Co. (www.harriswilliams.com), a member of The PNC Financial Services Group, Inc. (NYSE:PNC), is a preeminent middle market investment bank focused on the advisory needs of clients worldwide. The firm has deep industry knowledge, global transaction expertise and an unwavering commitment to excellence. Harris Williams & Co. provides sell-side and acquisition advisory, restructuring advisory, board advisory, private placements and capital markets advisory services. Harris Williams & Co.’s TMT Group advises leading private and public companies, entrepreneurs, private equity firms and venture capital firms on mergers and acquisitions and capital-raising transactions worldwide. The TMT Group has deep domain expertise in the Software/SaaS and Internet & Digital Media segments, with particular emphasis on specific verticals including education, energy technology, fintech, public sector and supply chain/logistics and has a dedicated healthcare technology (HCIT) practice. Across verticals it also advises technology services and networking solutions businesses. For more information on the TMT Group and its recent transactions, visit the TMT Group’s section of the Harris Williams & Co. website. Harris Williams & Co.’s Consumer Group has completed more than 50 transactions in recent years across a variety of verticals, including branded consumer products and travel; consumer services; food, beverage and agribusiness; and restaurant and retail. For more information on Harris Williams & Co.’s Consumer Group and other recent transactions, visit the Consumer Group’s section of the Harris Williams & Co. website. Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which is private limited company incorporated under English law with its registered office at 5th Floor, 6 St. Andrew Street, London EC4A 3AE, UK, registered with the Registrar of Companies for England and Wales (registration number 7078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. is a trade name under which Harris Williams LLC and Harris Williams & Co. Ltd conduct business.


News Article | November 4, 2016
Site: www.businesswire.com

NEW YORK--(BUSINESS WIRE)--Healthcare marketing agency Heartbeat is moving its NYC headquarters to a new location in midtown Manhattan at One Penn Plaza, 5th Floor, New York, NY 10119.


News Article | December 21, 2016
Site: www.businesswire.com

RICHMOND, Va.--(BUSINESS WIRE)--Harris Williams & Co., a preeminent middle market investment bank focused on the advisory needs of clients worldwide for 25 years, announces that Leeds Equity Partners, LLC, (Leeds) invested in Professional Science 360 Holdings, Inc. (Prosci) in partnership with the existing management team. Harris Williams & Co. served as the exclusive financial advisor to Prosci and Bow River Capital Partners (Bow River). The transaction was led by Derek Lewis and John Klim of Harris Williams & Co.’s Business Services Group and Mike Williams and Kyle Quearry of the firm’s Richmond office. “Prosci is an industry-leading change management firm and the company’s mix of proprietary, research-driven solutions has positioned the company for significant future growth. We have truly enjoyed working with the Prosci management team and look forward to following the company’s continued success,” said Derek Lewis, a managing director at Harris Williams & Co. Founded in 1994, Prosci is a change management firm focused on helping individuals and organizations build change management capabilities. Best practices research acts as the foundation for Prosci’s world-renowned change management training programs and tools, including the Prosci ADKAR® Model. Prosci has certified over 30,000 change leaders worldwide through the Prosci Change Management Certification Program. Founded in 2003, Bow River is a private alternative asset management company based in Denver, Colorado, with buyout, real estate, and energy fund platforms. Bow River’s buyout platform focuses on lower middle market operating companies, with an emphasis on human capital based businesses across a geographic area the principals refer to as Bow River’s Rodeo Region®, which encompasses the Rocky Mountains and surrounding states. Founded in 1993 by Jeffrey Leeds and Robert Bernstein, Leeds’ professionals have over 100 years of combined experience investing in the knowledge sector. The company has managed five funds to date and has deployed $1.2 billion of equity capital. Leeds’ twenty-year industry focus and expertise allows the company to apply the strategic insights of an experienced industry participant during the investment process and as partners with management. The company’s investors include many leading domestic and international institutions including pension funds, banks, insurance companies, diversified financial institutions, foundations, university endowments, family offices and high net worth individuals. Harris Williams & Co. (www.harriswilliams.com), a member of The PNC Financial Services Group, Inc. (NYSE:PNC), is a preeminent middle market investment bank focused on the advisory needs of clients worldwide. The firm has deep industry knowledge, global transaction expertise and an unwavering commitment to excellence. Harris Williams & Co. provides sell-side and acquisition advisory, restructuring advisory, board advisory, private placements and capital markets advisory services. Harris Williams & Co.’s Business Services Group has experience across a variety of sectors, including facility services; environmental services; business process outsourcing; legal and insurance services; marketing and information services; professional services; payment processing and financial services; and education and training. For more information on the firm’s Business Services Group and other recent transactions, visit the Business Services Group’s section of the Harris Williams & Co. website. Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which is private limited company incorporated under English law with its registered office at 5th Floor, 6 St. Andrew Street, London EC4A 3AE, UK, registered with the Registrar of Companies for England and Wales (registration number 7078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. is a trade name under which Harris Williams LLC and Harris Williams & Co. Ltd conduct business. For media inquiries, please contact Katie Hurst, associate brand manager, at +1 (804) 648-0072.


RICHMOND, Va.--(BUSINESS WIRE)--Harris Williams & Co., a preeminent middle market investment bank focused on the advisory needs of clients worldwide for 25 years, announces the sale of Lakeview Health Systems, LLC (Lakeview), a leading Joint Commission accredited substance abuse treatment provider, to The Riverside Company (Riverside). Harris Williams & Co. served as the exclusive financial advisor to Lakeview, a portfolio company of Trinity Hunt Partners (Trinity Hunt). The transaction was led by Cheairs Porter, James Clark, Paul Hepper, Jacques Fu and Whitt Larkin of Harris Williams & Co.’s Healthcare & Life Sciences (HCLS) Group. “Lakeview has distinguished itself as an industry leader among substance abuse treatment providers through its demonstrated track record of driving superior patient outcomes,” said Cheairs Porter, a managing director in Harris Williams & Co.’s HCLS Group. “The transaction illustrates the strong interest in high-quality substance abuse platforms, driven by the unmet need to treat a growing population of individuals with substance abuse disorders,” added James Clark, a managing director in Harris Williams & Co.’s HCLS Group. “Roy M. Serpa and his team have transformed the Lakeview platform into a center for excellence under Trinity Hunt’s ownership and positioned the company for significant future growth,” said Paul Hepper a director in Harris William & Co.’s HCLS Group. “Riverside will be an excellent partner to help management execute on its strategic plan and realize Lakeview’s growth potential.” Lakeview, located in Jacksonville, Florida, serves individuals with addiction and psychiatric disorders. Licensed clinical staff work in large and small groups to offer an integrative health approach that addresses the medical, psychological, physical and spiritual aspects of recovery. The company’s gender-responsive programs—the Rose of Lakeview and the Star of Lakeview—host unique treatment features that cater to women and men independently. Lakeview provides a full continuum of care that includes medical detox to intensive outpatient, allowing patients to successfully move toward a life in recovery. Trinity Hunt is a private equity firm based in Dallas focused on partnering with entrepreneurial businesses to accelerate their growth and achieve their full potential. With over $500 million of committed investor capital, the firm’s investment team has a successful track record investing in more than 50 platform companies over the past 25 years. Riverside is a global private equity firm focused on making control and non-control investments in growing businesses valued at up to $400 million. Since its founding in 1988, Riverside has invested in more than 450 transactions. The firm’s international portfolio includes more than 80 companies. Riverside has extensive healthcare services experience and has made more than 90 investments in the sector. Harris Williams & Co. (www.harriswilliams.com), a member of The PNC Financial Services Group, Inc. (NYSE:PNC), is a preeminent middle market investment bank focused on the advisory needs of clients worldwide. The firm has deep industry knowledge, global transaction expertise and an unwavering commitment to excellence. Harris Williams & Co. provides sell-side and acquisition advisory, restructuring advisory, board advisory, private placements and capital markets advisory services. Harris Williams & Co.’s HCLS Group has experience across a broad range of sectors, including multi-site and retail healthcare providers (including dental care providers); alternate site care; healthcare IT; managed care and cost containment services; medical devices, products and distribution; outsourced clinical services; and outsourced pharma services. For more information on the HCLS Group and other recent transactions, visit the HCLS Group’s section of the Harris Williams & Co. website. Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which is private limited company incorporated under English law with its registered office at 5th Floor, 6 St. Andrew Street, London EC4A 3AE, UK, registered with the Registrar of Companies for England and Wales (registration number 7078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. is a trade name under which Harris Williams LLC and Harris Williams & Co. Ltd conduct business.


News Article | November 1, 2016
Site: globenewswire.com

The Board would like to announce that the Annual General Meeting of the Company's shareholders will be held at 11.00 a.m. (London time) on Thursday 24th November 2016 at 5th Floor, 1 Tudor Street, London EC4A 0AH. The Notice of the meeting has been mailed to shareholders today and a copy is attached to this release. THE DIRECTORS OF OPTIMA WORLDWIDE GROUP PLC ACCEPT RESPONSIBILITY FOR THIS ANNOUNCEMENT Optima Worldwide Group PLC is the Parent company for the Group. The Group is engaged in the provision of financial and related professional services and holds investments in a number of companies, the principal operating subsidiaries being Brandon Hill Capital and Strand Capital, each being regulated by the UK Financial Conduct Authority ("FCA") Further information may be found at the Company's website: www.owgplc.com


News Article | March 2, 2017
Site: globenewswire.com

DUBLIN, Ireland, March 02, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today announced that it has commenced a registered underwritten public offering of 2,700,000 of its ordinary shares. All of the ordinary shares in the offering will be sold by Prothena.  In addition, Prothena has granted the underwriter a 30-day option to purchase up to an additional 405,000 of its ordinary shares. Cantor Fitzgerald & Co. is acting as the sole bookrunner for the offering. The ordinary shares of Prothena described above are being offered only by means of a prospectus supplement and base prospectus forming part of an effective shelf registration statement filed with the Securities and Exchange Commission. Copies of the prospectus for this offering may be obtained, when available, by contacting Cantor Fitzgerald & Co., Attn: Capital Markets, 499 Park Ave., 5th Floor, New York, New York 10022, or by telephone at 212-829-7122, or by e-mail at prospectus@cantor.com. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Prothena Corporation plc is a global, late-stage clinical biotechnology company with a clinical pipeline of novel therapeutic antibodies. Prothena is establishing a fully integrated research, development and commercial focus and has advanced several drug candidates into clinical studies while pursuing discovery of additional novel therapies. Our pipeline of antibody-based product candidates targets a number of potential indications including AL amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003), and ATTR amyloidosis (PRX004). This press release contains forward-looking statements. These statements relate to, among other things, the timing and size of the proposed offering, the conditions affecting the capital markets, general economic, industry, or political conditions, and the satisfaction of customary closing conditions related to the proposed offering. These statements are based on estimates, projections and assumptions that may prove not to be accurate, and actual results could differ materially from those anticipated due to known and unknown risks, uncertainties and other factors, including but not limited to the risks, uncertainties and other factors described in the "Risk Factors" sections of Prothena’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) on February 27, 2017 and in the preliminary prospectus supplement related to the proposed offering to be filed with the SEC on or about the date hereof. Prothena undertakes no obligation to update publicly any forward-looking statements contained in this press release as a result of new information, future events or changes in Prothena's expectations.


News Article | February 22, 2017
Site: globenewswire.com

MINNEAPOLIS, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced that Dawson James Securities, Inc., the underwriter of its previously announced public offering that closed on January 19, 2017, has exercised its option in full to purchase (i) 175,000 additional shares of common stock at the public offering price per unit less the price per warrant included in the unit and less the underwriting discount and (ii) Series D Warrants to purchase 35,000 additional shares of common stock at a purchase price of $0.01 per Series D Warrant to cover over-allotments. The shares of Common Stock and Series D Warrants are immediately separable and will be issued separately. The closing of the exercise of the over-allotment option occurred on February 22, 2017. Net proceeds to the Company from the exercise of the over-allotment in full were approximately $358,312 after deducting underwriting discounts and commissions but before deducting estimated offering expenses payable by the Company. The Company’s common stock is listed on The NASDAQ Capital Market under the symbol "SKLN". There is no established public trading market for the offered Series D Warrants and the Company does not expect a market to develop. In addition, the Company does not intend to apply for listing of the Series D Warrants on any national securities exchange. Dawson James Securities, Inc. acted as the sole underwriter for the offering. Copies of the complete final prospectus related to the offering may be obtained from Dawson James Securities, Inc., Attention: Prospectus Department, 1 North Federal Highway, 5th Floor, Boca Raton, FL 33432, or from mmaclaren@dawsonjames.com, or by calling toll free at 866.928.0928. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Skyline Medical Skyline Medical produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods that require hand carrying and emptying filled fluid canisters present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with OSHA and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and radiology and endoscopy departments, thereby leading to greater profitability, and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills each year in the U.S. For additional information, please visit www.skylinemedical.com. Forward-looking Statements Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the Company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; unexpected costs and operating deficits, and lower than expected sales and revenues; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance, if our product is not accepted by our potential customers, it is unlikely that we will ever become profitable, adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology, including the possibility that the development of applicable technologies by GLG Pharma, LLC will be delayed, will not occur or will not receive applicable regulatory approvals on a timely basis; the Company's ability to consummate its joint venture with Electronic On-Ramp, Inc.; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company's financial position. See the Company's most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov.

Loading 5th Floor collaborators
Loading 5th Floor collaborators